Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Asthma Immunotherapies market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Asthma Immunotherapiesmarket, defines the market attractiveness level of Asthma Immunotherapies market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Asthma Immunotherapies industry, describes the types of Asthma Immunotherapies market, the applications of major players and the market size, and deeply analyzes the current situation of the global Asthma Immunotherapies market and the development prospects and opportunities of Asthma Immunotherapies industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Asthma Immunotherapies market in Chapter 13.
By Player:
Leti Pharma
HAL Allergy Group
Merck KGaA (Allergopharma)
Jubliant Pharma (Hollister Allergy)
Stallergenes Greer
By Type:
Subcutaneous Immunotherapy
Sublingual Immunotherapy
By End-User:
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Asthma Immunotherapies Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Asthma Immunotherapies Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Asthma Immunotherapies Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Asthma Immunotherapies Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Asthma Immunotherapies Market Analysis and Outlook to 2022
-
7.1 Global Asthma Immunotherapies Consumption (2017-2022)
-
7.2 United States Asthma Immunotherapies Consumption (2017-2022)
-
7.3 Europe Asthma Immunotherapies Consumption (2017-2022)
-
7.4 China Asthma Immunotherapies Consumption (2017-2022)
-
7.5 Japan Asthma Immunotherapies Consumption (2017-2022)
-
7.6 India Asthma Immunotherapies Consumption (2017-2022)
-
7.7 South Korea Asthma Immunotherapies Consumption (2017-2022)
8 Region and Country-wise Asthma Immunotherapies Market Analysis and Outlook to 2028
-
8.1 Global Asthma Immunotherapies Consumption Forecast (2022-2028)
-
8.2 United States Asthma Immunotherapies Consumption Forecast (2022-2028)
-
8.3 Europe Asthma Immunotherapies Consumption Forecast (2022-2028)
-
8.4 China Asthma Immunotherapies Consumption Forecast (2022-2028)
-
8.5 Japan Asthma Immunotherapies Consumption Forecast (2022-2028)
-
8.6 India Asthma Immunotherapies Consumption Forecast (2022-2028)
-
8.7 South Korea Asthma Immunotherapies Consumption Forecast (2022-2028)
9 Global Asthma Immunotherapies Market Outlook by Types and Applications to 2022
-
9.1 Global Asthma Immunotherapies Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Subcutaneous Immunotherapy Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Sublingual Immunotherapy Consumption and Growth Rate (2017-2022)
-
9.2 Global Asthma Immunotherapies Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
10 Global Asthma Immunotherapies Market Outlook by Types and Applications to 2028
-
10.1 Global Asthma Immunotherapies Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Subcutaneous Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Sublingual Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Asthma Immunotherapies Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
11 Global Asthma Immunotherapies Import and Export Analysis (Top 5 Countries)
-
11.1 Global Asthma Immunotherapies Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Asthma Immunotherapies Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Asthma Immunotherapies Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Asthma Immunotherapies Market Competitive Analysis
-
14.1 Leti Pharma
-
14.1.1 Leti Pharma Company Details
-
14.1.2 Leti Pharma Asthma Immunotherapies Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Leti Pharma Asthma Immunotherapies Product and Service
-
14.2 HAL Allergy Group
-
14.2.1 HAL Allergy Group Company Details
-
14.2.2 HAL Allergy Group Asthma Immunotherapies Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 HAL Allergy Group Asthma Immunotherapies Product and Service
-
14.3 Merck KGaA (Allergopharma)
-
14.3.1 Merck KGaA (Allergopharma) Company Details
-
14.3.2 Merck KGaA (Allergopharma) Asthma Immunotherapies Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Merck KGaA (Allergopharma) Asthma Immunotherapies Product and Service
-
14.4 Jubliant Pharma (Hollister Allergy)
-
14.4.1 Jubliant Pharma (Hollister Allergy) Company Details
-
14.4.2 Jubliant Pharma (Hollister Allergy) Asthma Immunotherapies Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Jubliant Pharma (Hollister Allergy) Asthma Immunotherapies Product and Service
-
14.5 Stallergenes Greer
-
14.5.1 Stallergenes Greer Company Details
-
14.5.2 Stallergenes Greer Asthma Immunotherapies Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Stallergenes Greer Asthma Immunotherapies Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Asthma Immunotherapies
-
Figure Asthma Immunotherapies Picture
-
Table Global Asthma Immunotherapies Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Asthma Immunotherapies Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Asthma Immunotherapies Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Asthma Immunotherapies Consumption by Country (2017-2022)
-
Figure United States Asthma Immunotherapies Consumption and Growth Rate (2017-2022)
-
Table Europe Asthma Immunotherapies Consumption and Growth Rate (2017-2022)
-
Figure China Asthma Immunotherapies Consumption and Growth Rate (2017-2022)
-
Figure Japan Asthma Immunotherapies Consumption and Growth Rate (2017-2022)
-
Figure India Asthma Immunotherapies Consumption and Growth Rate (2017-2022)
-
Figure South Korea Asthma Immunotherapies Consumption and Growth Rate (2017-2022)
-
Figure Global Asthma Immunotherapies Consumption Forecast by Country (2022-2028)
-
Figure United States Asthma Immunotherapies Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Asthma Immunotherapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Asthma Immunotherapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Asthma Immunotherapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Asthma Immunotherapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Asthma Immunotherapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Subcutaneous Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Sublingual Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Subcutaneous Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Sublingual Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Asthma Immunotherapies Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Asthma Immunotherapies Export by Region (Top 5 Countries) (2017-2028)
-
Table Leti Pharma (Foundation Year, Company Profile and etc.)
-
Table Leti Pharma Asthma Immunotherapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Leti Pharma Asthma Immunotherapies Product and Service
-
Table HAL Allergy Group (Foundation Year, Company Profile and etc.)
-
Table HAL Allergy Group Asthma Immunotherapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table HAL Allergy Group Asthma Immunotherapies Product and Service
-
Table Merck KGaA (Allergopharma) (Foundation Year, Company Profile and etc.)
-
Table Merck KGaA (Allergopharma) Asthma Immunotherapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck KGaA (Allergopharma) Asthma Immunotherapies Product and Service
-
Table Jubliant Pharma (Hollister Allergy) (Foundation Year, Company Profile and etc.)
-
Table Jubliant Pharma (Hollister Allergy) Asthma Immunotherapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Jubliant Pharma (Hollister Allergy) Asthma Immunotherapies Product and Service
-
Table Stallergenes Greer (Foundation Year, Company Profile and etc.)
-
Table Stallergenes Greer Asthma Immunotherapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Stallergenes Greer Asthma Immunotherapies Product and Service
-
